ClinicalTrials.Veeva

Menu

Fluid Coloading and the Incidence of Hypotension

Ç

Çukurova University

Status and phase

Completed
Phase 4

Conditions

Complications; Cesarean Section
Other Fluid Overload
Anesthesia; Adverse Effect, Spinal and Epidural

Treatments

Biological: Cristalloid and colloid coloading

Study type

Interventional

Funder types

Other

Identifiers

NCT01741610
HZLTNS97

Details and patient eligibility

About

This study was conducted to evaluate the effects of rapid crystalloid (Lactated Ringer's solution) or colloid (hydroxyethyl starch; HES) cohydration with a second intravenous access line on the incidence of hypotension and ephedrine requirement during spinal anaesthesia for caesarean section.

Full description

Background: Spinal anaesthesia for caesarean delivery is often associated with hypotension. This study was conducted to evaluate the effects of rapid crystalloid (Lactated Ringer's solution) or colloid (hydroxyethyl starch; HES) cohydration with a second intravenous access line on the incidence of hypotension and ephedrine requirement during spinal anaesthesia for caesarean section.

Methods: We studied 90 women with uncomplicated pregnancies undergoing elective caesarean section under spinal anaesthesia. Intravenous access was established in all with two peripheral intravenous lines, the first being used for the baseline volume infusion. Immediately after induction of spinal anaesthesia, Lactated Ringer's solution (Group L) or HES (Group C) infusions were started at the maximal possible rate via the second line in groups L and C respectively. The third group (Group E) patients received lactated Ringer's solution at a 'keep vein open' rate to maintain the double-blind nature. The incidence of hypotension, ephedrine requirements, total amount of volume and side effects were recorded.

Enrollment

90 patients

Sex

Female

Ages

19 to 46 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • elective caesarean section under spinal anaesthesia

Exclusion criteria

  • Significant coexisting disease such as; pre-eclampsia and hepato-renal disease,
  • Pregnancy preinduced hypertension,
  • Being in active labour or requiring emergency caesarean section,
  • Any contraindication to regional anaesthesia such as local infection or bleeding disorders.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

90 participants in 3 patient groups, including a placebo group

No coloading (Group E)
Placebo Comparator group
Description:
Placebo comparator
Treatment:
Biological: Cristalloid and colloid coloading
Cristalloid (Lactated Ringer) Coloading
Active Comparator group
Description:
Cristalloid (Lactated Ringer's) Coloading (Group L)
Treatment:
Biological: Cristalloid and colloid coloading
Colloid (HES) coloading
Active Comparator group
Description:
Colloid (HES) coloading (Group C)
Treatment:
Biological: Cristalloid and colloid coloading

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems